-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S5/JeDb9+dBICcGAIKpoPLkPXE+Q2DG3cD8RMqGNvZuqNEkt/yMW/SMtjEI9Bx4H +/t1PpCrC6KxjKaP4RXfRQ== 0000950131-98-000671.txt : 19980313 0000950131-98-000671.hdr.sgml : 19980313 ACCESSION NUMBER: 0000950131-98-000671 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980205 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALLIED HEALTHCARE PRODUCTS INC CENTRAL INDEX KEY: 0000874710 STANDARD INDUSTRIAL CLASSIFICATION: 3842 IRS NUMBER: 251370721 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-43614 FILM NUMBER: 98522076 BUSINESS ADDRESS: STREET 1: 1720 SUBLETTE AVE CITY: ST LOUIS STATE: MI ZIP: 63110 BUSINESS PHONE: 3147712400 MAIL ADDRESS: STREET 1: 1720 SUBLETTE AVENUE CITY: ST LOUIS STATE: MO ZIP: 63110 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WASHINGTON UNIVERSITY CENTRAL INDEX KEY: 0000903603 STANDARD INDUSTRIAL CLASSIFICATION: 0000 IRS NUMBER: 430653611 STATE OF INCORPORATION: MO FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: CAMPUS BOX NUMBER 1058 STREET 2: ONE BROOKINGS DRIVE CITY: ST LOUIS STATE: MO ZIP: 63130-4899 BUSINESS PHONE: 314-935-5152 MAIL ADDRESS: STREET 1: CAMPUS BOX NUMBER 1058 STREET 2: ONE BROOKINGS DRIVE CITY: ST LOUIS STATE: MO ZIP: 63130 SC 13G 1 SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) Information statement pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. _____)* ALLIED HEALTHCARE PRODUCTS, INC. - - -------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK - - -------------------------------------------------------------------------------- (Title of Class of Securities) 019222 10 8 - - -------------------------------------------------------------------------------- (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 6 - - ----------------------- --------------------- CUSIP NO. 019222 10 8 SCHEDULE 13G Page 2 of 6 Pages - - ----------------------- --------------------- - - ------------------------------------------------------------------------------ NAME OF REPORTING PERSON 1 S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON THE WASHINGTON UNIVERSITY 43-0653611 - - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [_] (b) [_] - - ------------------------------------------------------------------------------ SEC USE ONLY 3 - - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4 MISSOURI - - ------------------------------------------------------------------------------ SOLE VOTING POWER 5 NUMBER OF 779,000 SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6 -0- OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7 REPORTING 779,000 PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8 -0- - - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9 779,000 - - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10 [_] - - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 11 9.9% - - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 12 EP - - ------------------------------------------------------------------------------ Schedule 13G Item 1. (a) Name of Issuer: ALLIED HEALTHCARE PRODUCTS, INC. (b) Address of Issuer's Principal Executive Offices: 1720 Sublette Avenue St. Louis, Missouri 63110 Item 2. (a) Name of Person Filing: THE WASHINGTON UNIVERSITY (b) Address of Principal Business Officer or, if none, Residence: Campus Box 1058 One Brookings Drive St. Louis, Missouri 63130 (c) Citizenship: Missouri (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 019222 10 8 Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is: f [x] Endowment Fund Item 4. Ownership. (a) Amount Beneficially Owned: 779,000 (b) Percent of Class: 9.9% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 779,000 (ii) shared power to vote or to direct the vote: -0- (iii) sole power to dispose or to direct the disposition of: 779,000 (iv) shared power to dispose or to direct the disposition of: -0- Item 5. Ownership of Five Percent or Less of a Class. n/a Item 6. Ownership of More than Five Percent on Behalf of Another Person. n/a Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. n/a Item 8. Identification and Classification of Members of the Group. n/a Item 9. Notice of Dissolution of the Group. n/a Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 28, 1998 THE WASHINGTON UNIVERSITY By: /s/ Barbara A. Feiner ------------------------------- Name: Barbara A. Feiner Title: Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----